
Pharmaceutical Product R&D and Manufacturer
ShanghaiNovember 21, 2023PR Newswire -- On November 16, at the 30th anniversary awards ceremony of the Japan Investor Relations Association (JIRA), Eisai Co., Ltd. was awarded by the Japan Investor Relations Association."Honorary Titles of 'Best Investor Relations (IR) Improvement Quality Enterprise' and 'Best Investor Relations Continuous Contribution Quality Enterprise'"。
This award commemorates the 30th anniversary of JIRA's establishment. It serves as both a special recognition for member companies that have consistently engaged in investor relations activities over the medium to long term, and an acknowledgment of the efforts made by companies to enhance appropriate levels of information disclosure and foster constructive dialogue. Based on the evaluation results from the past 17 years (2007 to 2023), the review committee selects the "Best Investor Relations Companies" from among the member companies. Additionally, companies that have continuously been awarded the title of "Best Quality Company for Improving Investor Relations" and have made outstanding contributions to investor relations over a long period are granted the title of "Best Quality Company for Sustained Contribution to Investor Relations." This year, a total of 70 companies have been honored with the titles of "Best Quality Company for Improving Investor Relations" and "Best Quality Company for Sustained Contribution to Investor Relations." For more details, please visit the JIRA homepage.https://www.jira.or.jp/english/
Eisai prioritizes the interests of patients and public health, meeting their diverse needs and contributing to the enhancement of their well-being (the "hhc" concept: human health care). Based on this corporate philosophy, we effectively realize social value by alleviating patients' health-related anxieties and reducing health disparities. To implement this concept, Eisai is committed to quantifying the value of non-financial capital, including social and employee impacts, to create long-term, sustainable corporate value. Through dialogue between investors and senior management, as well as the publication of the Value Creation Report, we communicate the connection between financial and non-financial values and demonstrate the visualization of non-financial value.
Eisai will continue to respect the rights of shareholders and investors, ensure the fairness and transparency of management, and commit to carrying out investor relations activities to help enhance corporate value.